Lidocaine For Treatment of Post-operative Pain From Donor Sites Following Burn Injury.
Status:
Active, not recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
Burn pain is known to be one the most severe forms of acute pain often requiring large
amounts of narcotics in addition to other adjuvants. Topical lidocaine is effective for
controlling pain in various settings including dressing changes of burns. The aim of this
study is to demonstrate the effectiveness of topical lidocaine in decreasing pain scores and
narcotic requirements when applied to donor graft sites while at the same time not
interfering with the standard of care TheraBond dressing. During this study the investiagtors
will be monitoring for evidence of delayed wound healing, and surgical site infection.